公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer | CHING-YAO YANG ; Fan M.H.; Miao C.H.; Liao Y.J.; RAY-HWANG YUAN ; Liu C.L. | MOLECULAR THERAPY-ONCOLYTICS | 33 | 34 | |
2019 | Ex vivo expanded human Vγ9vδ2 T-cells can suppress epithelial ovarian cancer cell growth | Mao T.L.; TSUI-LIEN MAO ; Liao Y.J.; Chen Y.J.; Yeh C.Y.; Liu C.L. | International Journal of Molecular Sciences | 10 | 7 | |
2022 | Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons | Huang C.Y.; Nicholson M.W.; Wang J.Y.; Ting C.Y.; Tsai M.H.; Cheng Y.C.; Liu C.L.; Chan D.Z.H.; Lee Y.C.; Hsu C.C.; YU-HSIANG HSU ; Yang C.F.; Chang C.M.C.; Ruan S.C.; Lin P.J.; Lin J.H.; Chen L.L.; Hsieh M.L.; Cheng Y.Y.; WAN-TSENG HSU ; Lin Y.L.; Chen C.H.; Hsu Y.H.; Wu Y.T.; Hacker T.A.; Wu J.C.; Kamp T.J.; Hsieh P.C.H. | Cell Reports | 14 | 11 | |
2019 | SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma | Liu C.L.; Pan H.W.; PAO-LING TORNG ; Fan M.H.; TSUI-LIEN MAO | Oncology Reports | 18 | 15 | |
2017 | Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer | TSUI-LIEN MAO ; Fan K.F.; Liu C.L. | Gene Therapy | 42 | 43 |